Cargando…
Blood-based epigenome-wide analyses of cognitive abilities
BACKGROUND: Blood-based markers of cognitive functioning might provide an accessible way to track neurodegeneration years prior to clinical manifestation of cognitive impairment and dementia. RESULTS: Using blood-based epigenome-wide analyses of general cognitive function, we show that individual di...
Autores principales: | McCartney, Daniel L., Hillary, Robert F., Conole, Eleanor L. S., Banos, Daniel Trejo, Gadd, Danni A., Walker, Rosie M., Nangle, Cliff, Flaig, Robin, Campbell, Archie, Murray, Alison D., Maniega, Susana Muñoz, Valdés-Hernández, María del C., Harris, Mathew A., Bastin, Mark E., Wardlaw, Joanna M., Harris, Sarah E., Porteous, David J., Tucker-Drob, Elliot M., McIntosh, Andrew M., Evans, Kathryn L., Deary, Ian J., Cox, Simon R., Robinson, Matthew R., Marioni, Riccardo E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762878/ https://www.ncbi.nlm.nih.gov/pubmed/35039062 http://dx.doi.org/10.1186/s13059-021-02596-5 |
Ejemplares similares
-
Creating and Validating a DNA Methylation-Based Proxy for Interleukin-6
por: Stevenson, Anna J, et al.
Publicado: (2021) -
Epigenetic scores for the circulating proteome as tools for disease prediction
por: Gadd, Danni A, et al.
Publicado: (2022) -
Correction: Epigenetic scores for the circulating proteome as tools for disease prediction
por: Gadd, Danni A, et al.
Publicado: (2023) -
Genome‐ and epigenome‐wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk
por: Hillary, Robert F., et al.
Publicado: (2022) -
DNA methylation in APOE: The relationship with Alzheimer's and with cardiovascular health
por: Mur, Jure, et al.
Publicado: (2020)